Prostate drug candidates face off in early safety trial
NCT ID NCT07444385
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests two versions of an experimental drug for benign prostatic hyperplasia (enlarged prostate) in 44 healthy adult men. Each participant receives both drugs at different times to compare safety and how the body processes them. The goal is to see which version may be better tolerated and absorbed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
H PLUS YANGJI HOSPITAL, Seoul
RECRUITINGSeoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a tiny scrotal procedure ease prostate troubles without surgery?
- Do common prostate drugs change the eye? a trial investigates
- Can a common prostate drug spare the eye during cataract surgery?
- Can needles ease Post-Surgery bladder troubles? a trial puts electroacupuncture to the test
- Can a Drug-Coated balloon ease an enlarged prostate without surgery?
- Does anesthesia choice affect clotting in prostate surgery? a trial investigates